Axelsson, Gisli Thor
Jonmundsson, Thorarinn
Woo, Youngjae
Frick, Elisabet Alexandra
Aspelund, Thor
Loureiro, Joseph J.
Orth, Anthony P.
Jennings, Lori L.
Gudmundsson, Gunnar
Emilsson, Valur
Gudmundsdottir, Valborg
Gudnason, Vilmundur
Funding for this research was provided by:
Háskóli Íslands (Eimskip University Fund, Postdoctoral Fund)
Novartis Pharmaceuticals Corporation
Landspítali Háskólasjúkrahús
Hjartavernd
National Institute on Aging (N01-AG-12100)
Althingi
Article History
Received: 21 July 2023
Accepted: 30 October 2023
First Online: 18 January 2024
Declarations
:
: Approval for the AGES-Reykjavik study was obtained from the National Bioethics Committee in Iceland that acts as the Institutional Review Board for the Icelandic Heart Association (approval number: VSN-00-063), and by the National Institute on Aging Intramural Institutional Review Board.
: Not applicable.
: JJL, YJW and LLJ are employees and stockholders of Novartis. GTA and GG report travel support from Boehringer-Ingelheim for work not related to the study. No other potential conflicts of interest relevant to this article were reported.